Clinical trial
Clinical Evaluation of Novel Biological Markers for the Prediction of Severe Acute Pancreatitis
NCT00786591 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of Novel Biological Markers for the Prediction of Severe Acute Pancreatitis
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- July 31, 2009
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis